Onconephrology is a new subspecialty of nephrology that recognizes the important
intersections of kidney disease with cancer. This intersection takes many forms and includes …

Tumor lysis syndrome is a metabolic complication that may follow the initiation of cancer
therapy. It commonly occurs in hematological malignant patients particularly non‐Hodgkin's …

Purpose Patients with hematologic malignancies are increasingly admitted to the intensive
care unit (ICU) when life-threatening events occur. We sought to report outcomes and …

Tumor lysis syndrome (TLS) is a potentially deadly complication of tumors or their treatment.
This syndrome consists of a constellation of laboratory findings such as hyperuricemia …

Tumor lysis syndrome (TLS) is a common cause of acute kidney injury in patients with
malignancies, and it is a frequent condition for which the nephrologist is consulted in the …

Cancer patients may develop a variety of kidney lesions that impair not only their immediate
survival but also limit the adequate treatment of the underlying malignant process. This …

Tumor lysis syndrome (TLS) is an oncologic emergency from the intracellular release of
material in lysing malignant cells. The earlier it is treated, the less likely it is to be harmful to …

Acute kidney injury (AKI) is a common complication of cancer that occurs in up to 50% of
neoplastic patients during the natural history of their disease; furthermore, it has a huge …

Leukemia and lymphoma are hematologic malignancies that can affect any age group.
Disease can be aggressive or indolent, often with multiorgan system involvement. Kidney …

Tumor lysis syndrome (TLS) is an uncommon but potentially life‐threatening complication
associated with the treatment of some cancers. If left untreated, TLS may result in acute renal …